Toripalimab as Salvage Monotherapy in Chinese Patients With Advanced Melanoma: 5-Year Follow-Up
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Five-Year Follow-Up of POLARIS-01 Phase II Trial: Toripalimab as Salvage Monotherapy in Chinese Patients With Advanced Melanoma
Oncologist 2024 Mar 28;[EPub Ahead of Print], B Tang, R Duan, X Zhang, S Qin, D Wu, J Chen, H Yao, Z Chi, J Guo, X YanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.